› $150,000,000 verdict in personal injury case
Two years ago, M.D. Anderson researchers announced a 7 percent drop in breast cancer rates which coincidentally occurred around the same time that women were being told by the media and their doctors of the possible link between hormone replacement therapy (HRT) and serious diseases and conditions such as breast cancer and heart disease.
Nevada’s attorney general is suing drug makers Wyeth and Pfizer for alleged deceptive trade practices and misleading the public about the safety of its hormone replacement therapy (HRT) drugs, according to RGJ.com.
Women who take breast cancer drugs Arimidex or generic tamoxifen and suffer with menopausal symptoms such as hot flashes, night sweats or painful joints may be less likely to have a reoccurrence of their cancer tumors, according to Reuters.
Postmenopausal women who experience a slump in their sex drive may rediscover their libido by taking the male sex hormone testosterone. However, researchers are unsure if there may be a link between the use of testosterone and breast cancer, according to FoodConsumer.org.
Wyeth, the pharmaceutical company that makes hormone replacement therapies Prempro and Premarin, announced today that it is ending its research in its signature areas of contraceptives and menopause treatments to focus on other female problems such as ovarian and breast cancers, according to the Associated Press/Washington Post.
Strong bones may make older, post-menopausal women at greater risk for breast cancer, according to a study conducted by University of Arizona, reported by KABC-TV in Los Angeles.
Bone scans are used to check for osteoporosis, a disease in which bones become fragile and more likely to break. Women are typically four times more likely than men to suffer from osteoporosis. Because there is a direct relationship between the lack of estrogen after menopause and the development of osteoporosis, most doctors advise older women to have bone density tests every year along with a mammogram.
Breast cancer is a disease that affects women all around the world. One in eight women in the U.S. has the disease, one out of 10 in Europe, and one out of 11 in Australia. In Pakistan, the ratio is three in 10.
Earlier this week, as part of October’s international breast cancer awareness month, leaders from Liaquat National Hospital in Pakistan addressed the issue and their concern over why so many Pakistani women are still unaware of the disease, according to the Daily Times.
Once thought of as a cure-all for a host of menopausal symptoms with benefits ranging from increased bone strength and protection against heart disease, hormone replacement therapy (HRT) continues to come under fire for causing more harm than good. Now researchers believe that women who survived breast cancer and then took HRT to relieve menopause symptoms may be at a significantly higher risk for breast cancer recurrence, according to Natural News.
How and when women take hormone replacement therapy (HRT) may affect their risk of heart attack, according to the Washington Post.
